Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population

Journal of Critical Care

Volumn 29, Issue 6, 2014, Pages 965-970

  Kweon, Oh Joo ^a   Choi, Jee Hye ^a   Park, Sang Kil ^a   Park, Ae Ja ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

Infection; Presepsin; Sepsis; Septic shock

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PRESEPSIN; PROCALCITONIN; UNCLASSIFIED DRUG; CALCITONIN; CD14 ANTIGEN; PEPTIDE FRAGMENT; PRESEPSIN PROTEIN, HUMAN; PROTEIN PRECURSOR;

ADULT; AGED; APACHE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MORTALITY; PATIENT ASSESSMENT; PATIENT MONITORING; PREDICTION; PROTEIN ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; SEPTIC SHOCK; AREA UNDER THE CURVE; BACTEREMIA; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; APACHE; AREA UNDER CURVE; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; ROC CURVE; SEPSIS;

EID: 84908137546     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.06.014     Document Type: Article

References (13)

1. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
2. Protti A., Singer M. Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care 2006, 10:228-234.
3. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
4. Christ-Crain M., Muller B. Procalcitonin in bacterial infections-hype, hope, more or less?. Swiss Med Wkly 2005, 135:451-460.
5. Shirakawa K., Naitou K., Hirose J., et al. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med 2011, 49:937-939.
6. Shozushima T., Takahashi G., Matsumoto N., et al. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother 2011, 17:764-769.
7. Endo S., Suzuki Y., Takahashi G., et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012, 18:891-897.
8. Mussap M., Puxeddu E., Burrai P., et al. Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges. J Matern Fetal Neonatal Med 2012, 25:51-53.
9. Okamura Y., Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 2011, 412:2157-2161.
10. Yaegashi Y., Shirakawa K., Sato N., et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 2005, 11:234-238.
11. Knaus W.A., Wagner D.P., Draper E.A., et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991, 100:1619-1636.
12. Cakir Madenci O., Yakupoglu S., Benzonana N., et al. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis. Burns 2014, 40:664-669.
13. Liu B., Chen Y.X., Yin Q., et al. Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department. Crit Care 2013, 17:R244-R255.